BINDER, Joseph John,CHO, Helen Kim,DERMYER, Michael Robert,JOOSS, Karin Ute,PIERCE, Brian Gregory,TAN, Joyce Tsi,TSAI, Van To
申请号：
AU2016202651
公开号：
AU2016202651A1
申请日:
2016.04.27
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
#$%^&*AU2016202651A120160519.pdf#####H: ft interwoven NRPortbl DCC FMT l0026890_ .docx-21/04/2016 ABSTRACT The present disclosure provides (a) isolated immunogenic PAA polypeptides； (b) isolated nucleic acid molecules encoding immunogenic PAA polypeptides； (c) vaccine compositions comprising an immunogenic PAA polypeptide or an isolated nucleic acid molecule encoding an immunogenic PAA polypeptide； (d) methods relating to uses of the polypeptides, nucleic acid molecules, and compositions； and (e) vaccine-based immunotherapy regimens which involve co-administration of a vaccine in combination with an immune-suppressive-cell inhibitor and an immune-effector-cell enhancer.
